Effects of α1-Adrenergic Blockade on Pulsatile Luteinizing Hormone, Follicle-Stimulating Hormone, and Prolactin Secretion in Polycystic Ovary Syndrome*
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Central noradrenergic mechanisms may participate in the regulation of pulsatile gonadotropin secretion in women with the polycystic ovary syndrome (PCO). To examine this possibility we measured serum LH, FSH, and PRL concentrations at 10-min intervals and total testosterone and 17 beta-estradiol at 60-min intervals for 8 h basally and during the infusion of the alpha 1-adrenoceptor antagonist thymoxamine (10 micrograms/kg X min) in 10 young women with PCO. Mean and integrated serum LH concentrations as well as LH pulse frequency were not significantly altered (P = NS) during the thymoxamine infusion. However, we found an increase in LH pulse amplitude as both net (P less than 0.002) and percent (P less than 0.002) increment, as well as mean LH peak values (P less than 0.05) during alpha 1-adrenergic blockade. There were no significant changes in pulsatile FSH and PRL secretion or gonadal sex steroids during these experimental conditions. These data suggest that in PCO patients, 1) brain noradrenergic mechanisms do not play a stimulatory role in regulating the frequency of pulsatile LH secretion, 2) central noradrenergic activity inhibits LH pulse amplitude, and 3) PRL and FSH pulsatility are not altered by central noradrenergic blockade.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Santen, R. J., & Bardin, C. W. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107454 · Cited by 706
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
BARRACLOUGH, C. A., & WISE, P. M. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-1-91 · Cited by 371
Bacopoulos, N. G., Hattox, S. E., & Roth, R. H. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90175-4 · Cited by 212
Kaufman, J., Kesner, J. S., WILSON, R. C., & Knobil, E. (1985) · Endocrinology · doi:10.1210/endo-116-4-1327 · Cited by 124
BURGER, C. W., KORSEN, T., VAN KESSEL, H., VAN DOP, P. A., CARON, F. J. M., & SCHOEMAKER, J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-6-1126 · Cited by 120
Løbo, R. A., Granger, L. R., Paul, W. L., Goebelsmann, U., & Mishell, D. R. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90324-1 · Cited by 118
Increased Luteinizing Hormone Sensitivity to Dopamine Inhibition in Polycystic Ovary Syndrome*
QUIGLEY, M. E., RAKOFF, J. S., & YEN, S. S. C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-2-231 · Cited by 114
Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids
DeMet, E. M., & Halaris, A. E. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90611-7 · Cited by 110
CUMMING, D. C., REID, R. L., QUIGLEY, M. E., REBAR, R. W., & YEN, S. S. C. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00114.x · Cited by 106
Evidence for altered catecholamine metabolism in polycystic ovary syndrome
Shoupe, D., & Løbo, R. A. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)90441-1 · Cited by 49
Effect of adrenergic blocking drugs on secretion of luteinizing hormone in the ovariectomized ewe.
Gl, J. (1977) · PubMed · Cited by 43
Apha‐adrenergic receptor blockade increases human REM sleep.
Oswald, I., Thacore, V., Adam, K., & Brezinova, V (1975) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1975.tb01565.x · Cited by 41
Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease
Paradisi, R., Venturoli, S., Pasquali, R., Capelli, M., Porcu, E., Fabbri, R., & Flamigni, C. (1986) · Journal of Endocrinological Investigation · doi:10.1007/bf03348085 · Cited by 38
Self-citationSTUDIES OF PROLACTIN SECRETION IN POLYCYSTIC OVARY SYNDROME
Murdoch, A. P., Dunlop, W., & Kendall-Taylor, P. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb00759.x · Cited by 35
Paradisi, R., Lodi, S., BOLELLI, G., et al. (1980) · European Journal of Endocrinology · doi:10.1530/acta.0.0940229 · Cited by 28
Self-citationTHYMOXAMINE AND AIRWAYS OBSTRUCTION
Griffin, T. P., Kamburoff, P. L., Prime, F. J., et al. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91011-2 · Cited by 25
Barnes, R. B., Cha, K., Lee, D. G., et al. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90688-5 · Cited by 15
Collier, J., Nachev, C., & Robinson, B. F. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07266.x · Cited by 14
Veldhuis, J. D., Rogol, A. D., Williams, F. A., & Johnson, M. L. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1292 · Cited by 13
Prolactin pulsatility in polycystic ovarian disease
Laatikainen, T. K., & Tulenheimo, A. (1985) · Journal of Endocrinological Investigation · doi:10.1007/bf03350674 · Cited by 8
Paradisi, R., MAGRINI, O., Venturoli, S., et al. (1985) · Hormone and Metabolic Research · doi:10.1055/s-2007-1013439 · Cited by 7
Self-citationRoquebert, J., Malek, A., Creuzet, M. H., et al. (1983) · PubMed · Cited by 2
Cited by
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301
“Neither study documented changes in mean LH concentrations or LH pulse frequency (Paradisi et al., 1987; Popovic and Spremovic, 1995).”
BackgroundNEUROENDOCRINE ASPECTS OF POLYCYSTIC OVARY SYNDROME
Marshall, J. C., & Eagleson, C. A. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70071-2 · Cited by 138
Adrenergic control of the secretion of anterior pituitary hormones
Al‐Damluji, S. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80180-6 · Cited by 90
Christman, G. M., Randolph, J. F., Kelch, R. P., & Marshall, J. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1278 · Cited by 68
Mechanisms of Hypothalamic-Pituitary-Gonadal Disruption in Polycystic Ovarian Syndrome
Barontini, M., Garcia-Rudaz, M. C., & Veldhuis, J. D. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00325-3 · Cited by 75
Metadata
- Authors
- PARADISI, R., VENTUROLI, S., CAPELLI, M., SPADA, M., GIAMBIASI, M. E., MAGRINI, O., PORCU, E., FABBRI, R., & FLAMIGNI, C.
- Affiliations
- University of Bologna (IT)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1987-11
- Volume
- 65
- Issue
- 5
- Pages
- 841-846
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2056280434
- Cited by
- 15
- References
- 23
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, alpha-1 adrenergic blockade, thymoxamine, pulsatile gonadotropin secretion, luteinizing hormone, follicle-stimulating hormone, prolactin, noradrenergic regulation, LH pulse amplitude, LH pulse frequency, gonadotropin pulsatility
- MeSH terms
- Adolescent, Adrenergic alpha-Antagonists, Adult, Female, Follicle Stimulating Hormone, Humans, Luteinizing Hormone, Polycystic Ovary Syndrome, Prolactin, Pulsatile Flow, Moxisylyte
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.